Form 8-K - Current report:
SEC Accession No. 0001193125-24-248079
Filing Date
2024-10-31
Accepted
2024-10-31 06:05:30
Documents
16
Period of Report
2024-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d787969d8k.htm   iXBRL 8-K 30684
2 EX-1.1 d787969dex11.htm EX-1.1 232599
3 EX-5.1 d787969dex51.htm EX-5.1 8600
7 GRAPHIC g787969g31d40.jpg GRAPHIC 3805
  Complete submission text file 0001193125-24-248079.txt   468432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vera-20241029.xsd EX-101.SCH 2836
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20241029_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20241029_pre.xml EX-101.PRE 11698
18 EXTRACTED XBRL INSTANCE DOCUMENT d787969d8k_htm.xml XML 3783
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 241412199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)